Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amphinex induced PCI of bleomycin in Recurrent Head and Neck Cancer
NCT01606566Phase 2Terminated
- Sponsor
- PCI Biotech
- Start
- Apr 2012
- Primary completion
- Aug 2015
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 6
01
Overview
A Phase 2 trial of fimaporfin in squamous cell carcinoma of the head and neck (HNSCC), sponsored by PCI Biotech. Started Apr 2012; status: terminated.
02
Drugs
fimaporfin
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT01606566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01606566.